Net shares · 365d
-4.9K
0 buy · 4.9K sell
Net value · 365d
-$116.3K
$0 in · $116.3K out
Sentiment · 365d
Net selling
0% buying · 100% selling
Open-market trades · 365d
1
0 buy · 4.9K sell
Trading track record · all companies
Not enough open-market trades to chart a track record yet.
Running net of open-market buys − sells across every company. Tap the line or a marker for details. ▲ buy · ▼ sell.
Transactions · 365d
-
PCRX Grant·A
Director
$0
10.9K sh
Own New
-
PCRX Grant·A
Director
$0
6.4K sh
Own +56%
-
PCRX Sell·S
Director
$116.3K
4.9K sh · $23.67
Own -30%
| Date▾ | Ticker | Type | Shares | Value |
|---|---|---|---|---|
| Jun 10, 2026 | PCRX | Grant A | 10.9K | $0 |
| Jun 10, 2026 | PCRX | Grant A | 6.4K | $0 |
| Aug 7, 2025 | PCRX | Sell S | 4.9K | $116.3K |
Buy Sell Non-market (grant · exercise · gift)
About BIGAL MARCELO
This profile aggregates every SEC Form 4 insider transaction reported by BIGAL MARCELO across all companies they trade. Open-market purchases (code P) and sales (code S) are the highest-signal, discretionary trades; grants (A), option exercises (M) and gifts (G) reflect compensation rather than conviction and carry no market price. Figures cover the selected period and update as new filings are ingested.